Identification of a new metabolite of GHB: gamma-hydroxybutyric acid glucuronide

Research output: Contribution to journalJournal articleResearchpeer-review

Ida Nymann Petersen, Christian Tortzen, Jesper Langgaard Kristensen, Daniel Sejer Pedersen, Torben Breindahl

Gamma-hydroxybutyric acid (GHB) is an important analyte in clinical and forensic toxicology with a narrow detection window of 3-6 h. In the search of improved detection methods, the existence in vivo of a glucuronated GHB metabolite (GHB-GLUC) was hypothesized. Chemically pure standards of GHB-GLUC and a deuterated analogue for chromatography were synthesized. Liquid chromatography and tandem mass spectrometry were used for targeted analysis in anonymous clinical urine samples (n = 50). GHB-GLUC was found in concentrations ranging from 0.11 to 5.0 µg/mL (mean: 1.3 ± 1.2 µg/mL). Thus far, this is the first report of a GHB glucuronide detected in biological samples. Given that glucuronides generally have longer half-life values than their corresponding free drugs, GHB-GLUC should theoretically be a biomarker of GHB intoxication. It is also proposed that the hitherto unexplained reports of elevated GHB concentrations in some biological samples, which has caused the setting of a relatively high cutoff value (10 µg/mL), represent total GHB measurements (sum of free GHB and actively chemically hydrolyzed GHB-GLUC). To address these challenges, the present study must be followed by comprehensive pharmacokinetic and stability studies after the controlled administration of GHB.
Original languageEnglish
JournalJournal of Analytical Toxicology
Volume37
Issue number5
Pages (from-to)291-7
Number of pages7
ISSN0146-4760
DOIs
Publication statusPublished - Jun 2013

ID: 45842261